检索

期
标题
作者
卷 17, 编号 2 (2020)
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension
Chazova I., Martynyuk T., Rodnenkov V., Gorieva B., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Haisheva L., Kameneva T.
PDF
(Rus)
卷 6, 编号 4 (2009)
Rationale for the use of sartans in patients with arterial hypertension
Stryuk R.
卷 14, 编号 2 (2017)
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
Chazova I., Martynyuk T., Accetto R., Sirenko Y., Vincelj J., JWidimsky J., Barbič-Žagar B., Arhipov M., Grinshtein Y., Ostroumova O., Galjavich A., Rotar' O., Haisheva L., Nedogoda S.
PDF
(Rus)
卷 13, 编号 4 (2016)
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
Ostroumova O., Garelik I., Karavashkina E.
PDF
(Rus)
卷 12, 编号 2 (2015)
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
Chazova E., Martyniuk T.
PDF
(Rus)
卷 18, 编号 1 (2021)
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.
PDF
(Rus)
卷 17, 编号 3 (2020)
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.
PDF
(Rus)
1 - 7 的 7 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##